Single‐nucleotide polymorphisms of VEGF‐A and VEGFR‐2 genes and risk of infantile hemangioma
- 9 July 2018
- journal article
- research article
- Published by Wiley in International Journal of Dermatology
- Vol. 57 (10) , 1201-1207
Abstract
Background: Infantile hemangioma (IH) is the most common vascular tumor of childhood and infancy. It is distinguished by rapid proliferation of endothelial cells during the first year of life followed by spontaneous regression thereafter. One of the possible factors responsible for the IH development is vascular endothelial grow factor (VEGF). The purpose of this study was to evaluate the influence of selected polymorphisms in the genes coding for VEGF‐A (+405 G/C, rs2010963; +936 C/T, rs3025039) and its receptor VEGFR‐2 (+1416 T/A, rs1870377; –271 G/A, rs7667298) on the susceptibility to infantile hemangioma.Methods: We performed a case–control study of 99 Polish children hospitalized due to IH and compared them with matched healthy control subjects. The polymorphisms were ascertained through genotyping by PCR‐RFLP assay, PCR‐HRM, or the allelic discrimination method.Results: The study revealed a lower odds of infantile hemangioma in individuals with GG genotype or G allele for +405 G/C VEGF‐A polymorphism (ORdis = 0.52, P = 0.023 and ORdis = 0.63, P = 0.025, respectively). No association was observed for the remaining VEGF and VEGFR‐2 polymorphisms and IH risk.Conclusions: In our study, none of the investigated VEGF‐A and VEGFR‐2 genes polymorphisms was found to be an independent prognostic marker for infantile hemangioma. However, there is evidence that individuals carrying at least one G allele of +405 G/C VEGF‐A polymorphism have significantly lower risk of IH.Keywords
Funding Information
- Polish Ministry of Science and Higher Education (N407691340)
This publication has 41 references indexed in Scilit:
- Serum‐Level Changes of Vascular Endothelial Growth Factor in Children with Infantile Hemangioma after Oral Propranolol TherapyPediatric Dermatology, 2013
- Rapamycin Inhibits Proliferation of Hemangioma Endothelial Cells by Reducing HIF-1-Dependent Expression of VEGFPLOS ONE, 2012
- Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic TherapiesGenes & Cancer, 2011
- Novel Functional Germline Variants in the VEGF Receptor 2 Gene and Their Effect on Gene Expression and Microvessel Density in Lung CancerClinical Cancer Research, 2011
- Targeting NF-κB in infantile hemangioma-derived stem cells reduces VEGF-A expressionAngiogenesis, 2010
- Corticosteroid Suppression of VEGF-A in Infantile Hemangioma-Derived Stem CellsNew England Journal of Medicine, 2010
- Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangiomaNature Medicine, 2008
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- The biology of VEGF and its receptorsNature Medicine, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001